BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Preclinical Founded: 2014 by John Valliant University collaborators: McMaster University Corporate partners: Johnson & Johnson, Isogenica Ltd....
BioCentury | May 4, 2018
Company News

Fusion to identify cancer candidates with Isogenica platform

...to Isogenica's CIS display technology which Fusion will use to identify and develop cancer therapeutics. Isogenica...
...solid tumors. Isogenica Ltd., Little Chesterford, U.K. Fusion Pharmaceuticals Inc., Hamilton, Ontario Business: Cancer Allison Johnson Fusion Pharmaceuticals Inc. Isogenica Ltd....
BioCentury | Mar 2, 2017
Company News

Undisclosed company gets rights to Isogenica llamdA library

...family of llamdA camelid single-domain antibody libraries for the discovery, development and commercialization of therapeutics. Isogenica...
..."downstream payments.” Isogenica declined to disclose financial details. Isogenica Ltd. , Little Chesterford, U.K. Business: Antibodies Shannon Lehnbeuter Isogenica Ltd....
BioCentury | Feb 10, 2017
Company News

Isogenica, Maverick Therapeutics deal

...Isogenica granted Maverick licenses to its family of camelid single-domain antibody library (llamdA). Isogenica will receive...
...be reached. Isogenica Ltd. , Little Chesterford, U.K. Maverick Therapeutics Inc. , Brisbane, Calif. Business: Cancer Alicia Parker Isogenica Ltd. Maverick...
BioCentury | Sep 8, 2014
Company News

Isogenica management update

Isogenica Ltd. , Little Chesterford, U.K. Business: Genomics, Proteomics, Supply/Service Transitioning: CSO Chris Ullman to CEO, effective Sept. 29; he will succeed Kevin Matthews, who will become CEO of Revolymer Ltd. WIR Staff...
BioCentury | Jul 23, 2012
Company News

Isogenica, Research Corporation Technologies Inc. deal

...Research Corporation received an option to license Isogenica's CIS display technology. Research Corporation said it would...
...an antibody's CH2 domain and are engineered for enhanced stability, epitope binding and other properties. Isogenica Ltd....
BioCentury | Jun 11, 2012
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica computational chemistry/biology news

...to develop a highly-scalable discovery platform to identify diverse small molecules against therapeutic targets using Isogenica's...
...2011). Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd. , Welwyn Garden City, U.K. Isogenica Ltd....
BioCentury | May 14, 2012
Company News

Isogenica high throughput screening news

...The company received the award as part of a 10-member peptide screening consortium to combine Isogenica's...
...system for "deep screening" of peptide libraries against therapeutic targets. Isogenica Ltd. , Little Chesterford, U.K. Isogenica...
...The company received the award as part of a 10-member peptide screening consortium to combine Isogenica's...
BioCentury | Jul 4, 2011
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica deal

...identify small molecules against therapeutic targets. The companies will use Cresset's field-based computational chemistry and Isogenica's...
...disclosed. Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd. , Welwyn Garden City, U.K. Isogenica Ltd....
BioCentury | Feb 28, 2011
Company News

Isogenica, Phylogica deal

...completed a proof of concept (POC) project under a 2010 deal demonstrating the compatibility of Isogenica's...
...with Phylogica's Phylomer drug discovery platform for peptide engineering and drug discovery. Under the deal, Isogenica...
...ligand (CD154) for inflammatory diseases (see BioCentury, Feb. 8, 2010). Further details were not disclosed. Isogenica Ltd....
Items per page:
1 - 10 of 35
BioCentury | Jun 7, 2018
Emerging Company Profile

Radio fusion

...Preclinical Founded: 2014 by John Valliant University collaborators: McMaster University Corporate partners: Johnson & Johnson, Isogenica Ltd....
BioCentury | May 4, 2018
Company News

Fusion to identify cancer candidates with Isogenica platform

...to Isogenica's CIS display technology which Fusion will use to identify and develop cancer therapeutics. Isogenica...
...solid tumors. Isogenica Ltd., Little Chesterford, U.K. Fusion Pharmaceuticals Inc., Hamilton, Ontario Business: Cancer Allison Johnson Fusion Pharmaceuticals Inc. Isogenica Ltd....
BioCentury | Mar 2, 2017
Company News

Undisclosed company gets rights to Isogenica llamdA library

...family of llamdA camelid single-domain antibody libraries for the discovery, development and commercialization of therapeutics. Isogenica...
..."downstream payments.” Isogenica declined to disclose financial details. Isogenica Ltd. , Little Chesterford, U.K. Business: Antibodies Shannon Lehnbeuter Isogenica Ltd....
BioCentury | Feb 10, 2017
Company News

Isogenica, Maverick Therapeutics deal

...Isogenica granted Maverick licenses to its family of camelid single-domain antibody library (llamdA). Isogenica will receive...
...be reached. Isogenica Ltd. , Little Chesterford, U.K. Maverick Therapeutics Inc. , Brisbane, Calif. Business: Cancer Alicia Parker Isogenica Ltd. Maverick...
BioCentury | Sep 8, 2014
Company News

Isogenica management update

Isogenica Ltd. , Little Chesterford, U.K. Business: Genomics, Proteomics, Supply/Service Transitioning: CSO Chris Ullman to CEO, effective Sept. 29; he will succeed Kevin Matthews, who will become CEO of Revolymer Ltd. WIR Staff...
BioCentury | Jul 23, 2012
Company News

Isogenica, Research Corporation Technologies Inc. deal

...Research Corporation received an option to license Isogenica's CIS display technology. Research Corporation said it would...
...an antibody's CH2 domain and are engineered for enhanced stability, epitope binding and other properties. Isogenica Ltd....
BioCentury | Jun 11, 2012
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica computational chemistry/biology news

...to develop a highly-scalable discovery platform to identify diverse small molecules against therapeutic targets using Isogenica's...
...2011). Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd. , Welwyn Garden City, U.K. Isogenica Ltd....
BioCentury | May 14, 2012
Company News

Isogenica high throughput screening news

...The company received the award as part of a 10-member peptide screening consortium to combine Isogenica's...
...system for "deep screening" of peptide libraries against therapeutic targets. Isogenica Ltd. , Little Chesterford, U.K. Isogenica...
...The company received the award as part of a 10-member peptide screening consortium to combine Isogenica's...
BioCentury | Jul 4, 2011
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica deal

...identify small molecules against therapeutic targets. The companies will use Cresset's field-based computational chemistry and Isogenica's...
...disclosed. Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd. , Welwyn Garden City, U.K. Isogenica Ltd....
BioCentury | Feb 28, 2011
Company News

Isogenica, Phylogica deal

...completed a proof of concept (POC) project under a 2010 deal demonstrating the compatibility of Isogenica's...
...with Phylogica's Phylomer drug discovery platform for peptide engineering and drug discovery. Under the deal, Isogenica...
...ligand (CD154) for inflammatory diseases (see BioCentury, Feb. 8, 2010). Further details were not disclosed. Isogenica Ltd....
Items per page:
1 - 10 of 35